Loss or gain of function of specific miRNAs appears to be a key event in the genesis of diverse cancers including GC, such that miRNAs are now known to regulate pathways controlled by classic tumor suppressors and oncogenes including p53, myc and ras [49]; these genes are all involved in GC. The gene discussed is MYC; the disease is neoplasm.